SOLACE
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 24 Mar 2025)
What this means for you
Registered since 26 Jun 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87266689
- Registration number
- 5503997
- Mark type
- Stylized text
- Filed
- 13 Dec 2016
- Published for opposition
- 05 Dec 2017
- Registered
- 26 Jun 2018
- Attorney of record
- Mark E. Wiemelt
Goods and services
- Class 005 — Pharmaceuticals: FDA-cleared pharmaceutical preparations for use in the treatment of dermatological diseases, disorders and conditions in humans; FDA-cleared medicated dermatological preparations and substances for use by humans
Owner
- RESILIA PHARMACEUTICALS, INC., ATLANTA, GA, US
- PELLE VENTURES, LLC, HOLLAND, MI, US
- PELLE VENTURES, LLC, HOLLAND, MI, US
- PELLE VENTURES, LLC, HOLLAND, MI, US
Prosecution history
- 24 Mar 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 24 Mar 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 24 Mar 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Dec 2024 — TEAS SECTION 8 & 15 RECEIVED
- 26 Jun 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 May 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 26 Jun 2018 — REGISTERED-PRINCIPAL REGISTER
- 19 May 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 May 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Apr 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Apr 2018 — USE AMENDMENT FILED
- 27 Apr 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Apr 2018 — TEAS STATEMENT OF USE RECEIVED
- 30 Jan 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 05 Dec 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED